Patients with moderate to severe atopic dermatitis (AD)—or eczema—may be successfully treated using a rheumatoid arthritis (RA) drug recently shown to reverse 2 other skin conditions, vitiligo and alopecia areata, according to findings published early online in the Journal of the American Academy of Dermatology.
In part two of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses environmental and microbial triggers and when to choose systemic therapies with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
Eating peanuts in the first year of life dramatically reduces the likelihood that an infant at moderate risk for peanut allergy will develop the allergy, a randomized controlled trial in the United Kingdom showed.
There is increasing interest in so-called alternative medicine. Both patients and practitioners are clearly interested in this domain and this is in striking contrast to the bright, shining edifice of evidence-based medicine.
In a study of nearly 5,000 people with and without eczema, researchers have found those with eczema are more likely to have osteoporosis and fractures than adults without the skin condition. Learn more on the study.
Dermatology Times editorial advisor, Elaine Siegfried, M.D., talks with Peter Lio, M.D., assistant professor of clinical dermatology and pediatrics at Northwestern University’s Feinberg School of Medicine, and private practice, Dermatology and Aesthetics of Wicker Park, Wicker Park, Chicago, about his interest in alternative medicine and the legitimacy and usefulness of certain techniques and therapies.
The bad news is that office visits for atopic dermatitis are on the rise; the good news is that the condition usually responds to topical therapy and vigilant skin care, according to a clinical report from the American Academy of Pediatrics.